17 Sep 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
17 Sep 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
12 May 2025 Date | | - Cons. EPS | - EPS |
10 Feb 2025 Date | | - Cons. EPS | - EPS |
11 Nov 2024 Date | | - Cons. EPS | - EPS |
17 Sep 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
17 Sep 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
12 May 2025 Date | | - Cons. EPS | - EPS |
10 Feb 2025 Date | | - Cons. EPS | - EPS |
11 Nov 2024 Date | | - Cons. EPS | - EPS |
Aerospace & Defense Industry | Industrials Sector | Thomas Boone Pickens III CEO | NASDAQ (CM) Exchange | 046484200 Cusip |
US Country | 30 Employees | - Last Dividend | 5 Dec 2022 Last Split | 20 Dec 1995 IPO Date |
Astrotech Corporation, previously known as SPACEHAB, Inc., rebranded in 2009 and has its roots going back to 1984. Based in Austin, Texas, the company operates on a global scale, primarily focusing on mass spectrometry, a technology that allows the analysis of the chemical composition of substances. Astrotech Corporation is recognized for its proprietary Astrotech Mass Spectrometer Technology, which demonstrates the company's significant contribution to intellectual property in the mass spectrometry field. By developing and licensing this technology, Astrotech serves various markets, including security, agriculture, and healthcare, showcasing its versatile applications.
TRACER 1000: A cutting-edge mass spectrometer-based explosive trace detector designed to replace older detectors at critical locations such as airports, cargo facilities, secured entry points, and borders. The TRACER 1000 stands out for its sensitivity and reliability, aiming to enhance existing security measures by providing rapid and accurate detection of a wide range of explosive materials.
AgLAB-1000: Developed specifically for the burgeoning hemp and cannabis market, the AgLAB-1000 mass spectrometer is a testament to Astrotech's adaptability to emerging industries. This device aids in the precise analysis of cannabis and hemp, ensuring quality and compliance with evolving regulatory standards. Its targeted applications within the agriculture sector underscore the device's importance in improving product quality and safety.
BreathTest-1000: This innovative breath analysis tool represents a significant leap forward in medical diagnostics. Designed to detect volatile organic compound metabolites in human breath, the BreathTest-1000 could revolutionize the way diseases are screened and diagnosed. By non-invasively screening for biomarkers associated with certain diseases, this device has the potential to facilitate early detection and monitoring of health conditions, thus improving patient care and outcomes.